Go to deals
TMT

QUANTUM Data Analytics has formed a JV with AI-42 Market Intelligence

QUANTUM Advisory & Data Analytics International GmbH (QUANTUM) has entered into a joint venture with AI-42 Market Intelligence Ltd.

QUANTUM, via the Quantum Terminal, explores each technological element of a company’s IP to form an individual knowledge profile. Combined with fundamental data, it draws a precise picture and gains completely new insights into more than 700,000 companies worldwide. The company’s corporate IP analytics dataset is rigorously matched with public and private companies worldwide and covers practically all patent data generated since electronic recording began. Indicators from top universities (Harvard, University of California, University of Hong Kong) and renowned institutions (OECD, NBER) have been implemented to provide unparalleled IP analytics.

AI-42 Market Intelligence is a UK-based leading artificial intelligence market provider.

Oaklins’ team in Austria structured the joint venture QUANTUM Advisory & Data Analytics International GmbH as a subsidiary of Oaklins Austria and AI-42 Market Intelligence Ltd.

Parties

Talk to the deal team

 Thomas  Jungreithmeir

Thomas Jungreithmeir

Managing Partner
Vienna, Austria
Oaklins Austria

Related deals

Conzylum has been acquired by EPAM Systems, Inc.
TMT

Conzylum has been acquired by EPAM Systems, Inc.

Conzylum has been sold to EPAM Systems, Inc. (EPAM).

Learn more
Global IT Group has joined forces with enthus Group
Private Equity | TMT

Global IT Group has joined forces with enthus Group

Global IT Group, an IT services company, and enthus Group GmbH, an IT solution provider operating in Germany, Austria and Switzerland, have joined forces. As a result, enthus Group will significantly expand its market position in Switzerland. The sellers of Global IT have reinvested in the buyer and will ensure that local management continues to run the company as part of the succession planning.

Learn more
Cara Care has been acquired by Mahana Therapeutics
Private Equity | Healthcare | TMT

Cara Care has been acquired by Mahana Therapeutics

Mahana Therapeutics Inc., renowned for its pioneering digital treatments targeting chronic health issues, has recently finalized the acquisition of Cara Care (HiDoc Technologies GmbH). Cara Care stands out as a premier digital health platform and an official digital health application (DiGA) dedicated to enhancing gut health. This acquisition, supported by key investors Lux Capital and Jazz Ventures Partners, perfectly aligns with Mahana’s expansion strategy.

Learn more